Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-024912
Filing Date
2024-02-16
Accepted
2024-02-16 16:14:23
Documents
2
Group Members
ACTON TOWN INTERNATIONAL LTDALL BRILLIANCE INVESTMENTS LTDAPEX PRIDE GLOBAL LTDHOPEFUL WORLD CO LTDNAN ZHANGRUI MIXU ZHANG

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246551d1_sc13ga.htm SC 13G/A 164731
2 EXHIBIT A tm246551d1_ex99-a.htm EX-99.A 22218
  Complete submission text file 0001104659-24-024912.txt   188772
Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629
Business Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK DAXING DISTRICT, BEIJING F4 102629 17327133678
YS Biopharma Co., Ltd. (Subject) CIK: 0001946399 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-94412 | Film No.: 24648498
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK, DAXING BEIJING F4 00000
Business Address
Zhang /MD Yi (Filed by) CIK: 0002012319 (see all company filings)

Type: SC 13G/A